BROWSE·page 88 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


EX-10.2

Compass Diversified Holdings

NOTHING CONTAINED IN THIS SETTLEMENT AGREEMENT AND MUTUAL RELEASE SHALL BE AN ADMISSION OF FACT OR LIABILITY OR, UNTIL THE OCCURRENCE OF THE EFFECTIVE DATE ON THE TERMS DESCRIBED IN THIS AGREEMENT, DEEMED BINDING ON ANY OF THE PARTIES TO THIS AGREEMENT.

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

This SETTLEMENT AGREEMENT AND MUTUAL RELEASE (this, “Agreement”) is made and entered into by and among (i) Lugano Diamonds & Jewelry Inc., (ii) Lugano Buyer, Inc., (iii) K.L.D. Jewelry, LLC, (iv) Lugano Prive, LLC, (v) Lugano Holding, Inc. (together with the entities identified in (i)-(iv), the “Debtors”), (vi) Compass Diversified Holdings (“CODI Parent”); (vii) Compass Group Diversified Holdings LLC (“CODI”), (viii) Compass Group Management LLC (“CGM”), (ix) Sostratus, LLC (“Sostratus”), and (x) the Official Committee of Unsecured Creditors of the Debtors (the “UCC”). The Debtors, CODI, CGM, Sostratus, and the UCC are each referred to herein individually as a “Party” and collectively as the “Parties.”

RECITALS

…

EX-10.2·10-Q·CIK 1345122·ACC 0001345126-26-000061·Filed Aug 10, 2026, 16:13 ET

EX-10.24

Consolidated Water Co. Ltd.

EXHIBIT 10.24

CONSOLIDATED WATER CO. LTD.
2027 EMPLOYEE STOCK INCENTIVE PLAN

Article 1**​
**GENERAL

Section 1.1Purpose, Effective Date and Term.  The purpose of the Consolidated Water Co. Ltd.  2027 Employee Stock Incentive Plan (the “Plan”)is to promote the long-term financial success of the Consolidated Water Co. Ltd.  (the “Company”), a Cayman Islands holding company and its successors, assigns and Subsidiaries, by providing a means to attract, retain and reward individuals who contribute to that success and to further align their interests with those of the Company’s stockholders through the ownership of shares of Company Stock.  The “Effective Date” of the Plan shall be the date on which the Plan satisfies the applicable stockholder approval requirements.  The Plan will remain in effect as long as any Awards remain outstanding; *provided, however, *that no Awards may be granted under the Plan after the day immediately prior to the ten-year anniversary of the Effective Date.

…

EX-10.24·10-Q·CIK 928340·ACC 0001104659-26-093370·Filed Aug 10, 2026, 16:12 ET

EX-10.1

Metagenomi Therapeutics, Inc.

10.1

SUBLEASE

BASIC SUBLEASE INFORMATION

…

EX-10.1·10-Q·CIK 1785279·ACC 0001193125-26-342400·Filed Aug 10, 2026, 16:12 ET

EX-10.2

Sana Biotechnology, Inc.

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED PURSUANT TO ITEM 601(B)(10)(IV) OF REGULATION S-K BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

SECOND AMENDMENT

to the

Exclusive Licensing Agreement

Effective 2ndday of January, 2019

Between

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

and

SANA BIOTECHNOLOGY, INC.

Effective 1stday of May, 2026, (the “Second Amendment Effective Date”) THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (“THE REGENTS”), a California public corporation, having its statewide administrative offices at 1111 Franklin Street, 12th Floor, Oakland, California 94607-5200 and acting through its Office of Technology Management & Advancement, University of California San Francisco (“UCSF”), 490 Illinois Street, North Tower, 5th Floor, 500B San Francisco, CA 94158 and Sana Biotechnology, Inc, a Delaware corporation, having a principal place of business at 188 East Blaine Street, Suite 350, Seattle, WA 98102 (“LICENSEE”), agree as follows:

…

EX-10.2·10-Q·CIK 1770121·ACC 0001193125-26-342395·Filed Aug 10, 2026, 16:11 ET

EXHIBIT 10.1

CEVA INC

**AMENDMENT TO **

CEVA, INC.

2003 DIRECTOR STOCK OPTION PLAN

THIS AMENDMENT TO CEVA, INC. 2003 DIRECTOR STOCK OPTION PLAN, AS AMENDED AND RESTATED EFFECTIVE MAY 15, 2007 AND MAY 17, 2011 (this “Amendment”) is made and adopted by the Board of Directors (the “Board”) of Ceva, Inc., a Delaware corporation (the “Corporation”), as of May 7, 2026 (the “Effective Date”). Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Plan (as defined below).

RECITALS

WHEREAS, the Company maintains the Ceva, Inc. 2003 Director Stock Option Plan (as amended and restated effective May 15, 2007 and May 17, 2011, the “Plan”);

WHEREAS, pursuant to Section 9 of the Plan, the Plan may be amended or otherwise modified from time to time by the Board; and

WHEREAS, the Board desires to amend the Plan as set forth herein.

NOW, THEREFORE, BE IT RESOLVED, that the Plan is hereby amended as set forth herein, effective as of the Effective Date.

AMENDMENT

…

EX-10.1·10-Q·CIK 1173489·ACC 0001437749-26-026774·Filed Aug 10, 2026, 16:11 ET

EX-10.3

Olema Pharmaceuticals, Inc.

FOURTH amendment

to

Loan and securityagreement

This Fourth Amendment to Loan and Security Agreement (this“Amendment”) is entered into this 1stday of July, 2026, by and between Silicon Valley Bank, a division of First-Citizens Bank & Trust Company (“Bank”) and OLEMA PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”).

Recitals

A.Bank and Borrower have entered into that certain Loan and Security Agreement dated as of September 5, 2023, as further amended by that certain First Amendment to Loan and Security Agreement dated as of June 28, 2024, as amended by that certain Second Amendment to Loan and Security Agreement dated as of June 27, 2025, and as further amended by that certain Third Amendment to Loan and Security Agreement dated as of January 11, 2026 (the “Third Amendment”) (as the same may from time to time be further amended, modified, supplemented or restated, the “Loan Agreement”).

B.Bank has extended credit to Borrower for the purposes permitted in the Loan Agreement.

…

EX-10.3·10-Q·CIK 1750284·ACC 0001193125-26-342383·Filed Aug 10, 2026, 16:10 ET

EX-10.1

PROKIDNEY CORP.

May 16, 2026

Kenneth T. Locke

Dear Kenneth:

1.

This letter agreement (this “Agreement”) sets forth the terms and conditions of your

continued employment with ProKidney, LLC, a Delaware limited liability company (the “Company”) as of June1, 2026 (the “Effective Date”). The period during which you are employed by the Company pursuant to this Agreement shall be referred to as the “Term.”

This Agreement will govern your employment with the Company following the Effective Date on the following terms and conditions:

Position: Chief Technical Officer

Reporting: You will report directly to the Chief Executive Officer (“Supervisor”).

Duties and Commitment: You shall be employed by the Company on a full-time basis and shall perform such duties and responsibilities on behalf of the Company and its subsidiaries and affiliates (collectively, the “Company Group”) as are consistent with your position, and such additional duties and responsibilities on behalf of the Company Group, as may be designated from time to time by the Supervisor.

…

EX-10.1·10-Q·CIK 1850270·ACC 0001193125-26-342373·Filed Aug 10, 2026, 16:10 ET

EX-10.2

Bionano Genomics, Inc.

BIONANO GENOMICS, INC.

CONSULTING AGREEMENT

This Consulting Agreement(“Agreement”) is entered into as of May 06, 2026 by and between Bionano Genomics, Inc., a Delaware corporation having its principal place of business located at 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121 (collectively with its affiliates, “Company”), and R. Erik Holmlin, Ph.D.(“Consultant”).

The Company desires to retain Consultant as an independent contractor to perform consulting services for the Company and Consultant is willing to perform such services, on the terms described below.

Agreement

In consideration of the mutual promises contained herein, the parties agree as follows:

1.

…

EX-10.2·10-Q·CIK 1411690·ACC 0001411690-26-000044·Filed Aug 10, 2026, 16:10 ET

EX-10.1

Bionano Genomics, Inc.

May 6, 2026

Albert Luderer, Ph.D.

Dear Dr. Luderer:

It is a pleasure to confirm an offer of employment with Bionano Genomics, Inc. (the “Company”) to you for the full-time position of Interim Chief Executive Officer. Your employment will terminate upon the appointment by the Company of a permanent Chief Executive Officer. However, your employment will be “at will” and can be terminated by you or the Company at any earlier time for any reason. You will not be entitled to any severance benefits upon your cessation of employment, irrespective of the reason for your cessation of employment.

…

EX-10.1·10-Q·CIK 1411690·ACC 0001411690-26-000044·Filed Aug 10, 2026, 16:10 ET

EX-10.8

SUMISHO AIR LEASE CORP

Execution Version

Dated    May 2026

DAVID SWAN

-and-

ALC AIRCRAFT LIMITED

EMPLOYMENT AGREEMENT

THIS AGREEMENT made on this    day of May 2026 BETWEEN:

(1)ALC Aircraft Limited whose registered office is at 22 Earlsfort Terrace, Dublin 2 (the Company); and

(2)DAVID SWAN of, Springfield, 28a Sydney Ave, Blackrock, Dublin, A94 X2X9, Ireland (the Employee). (the Parties)

The Parties agree that the Employee will be employed by the Company, subject to the following terms and conditions:

1PRE-CONDITIONS TO EMPLOYMENT

1.1The Employee is free from any obligations owed to a third party which might prevent them from starting work on the commencement date of this contract or from properly performing the duties of their position; and

…

EX-10.8·10-Q·CIK 1487712·ACC 0001628280-26-055220·Filed Aug 10, 2026, 16:08 ET

EX-10.9

SUMISHO AIR LEASE CORP

Sabrina Lemmens

[*]

January 23, 2026

Private & Confidential

Re:     Offer of Employment with Sumisho

Dear Sabrina,

In anticipation of completion of the acquisition of Air Lease Corporation by Sumitomo Corporation, SMBC Aviation Capital, Apollo and Brookfield, we are very pleased to make an offer in principle to you for the role of Executive Vice President and Chief Financial Officer of Sumisho Air Lease Corporation.

Pre-condition

This offer in principle is subject to the completion of the transaction contemplated by the Agreement and Plan of Merger dated as of September 1, 2025, among Air Lease Corporation, Gladiatora Designated Activity Company (now Sumisho Air Lease Corporation DAC) and Takeoff Merger Sub Inc. (the “Transaction”). Following completion of the Transaction, your employer will be Sumisho Air Lease Corporation (“Sumisho” or the “Company”), and you will receive a formal offer letter memorializing and confirming the terms and conditions of your employment.

Terms of Offer

| | | | | | | | |

EX-10.9·10-Q·CIK 1487712·ACC 0001628280-26-055220·Filed Aug 10, 2026, 16:08 ET

EX-10.10

SUMISHO AIR LEASE CORP

[Date]

Private & Confidential

[Name]
[Title]

Dear [Name],

Re: Tax Equalization for Business Travel

This letter confirms the tax treatment that will apply to your approved international business travel on behalf of Sumisho Air Lease Corporation and its subsidiaries (collectively, the “Company”).

As a result of your business travel, you may become subject to income tax reporting or withholding obligations in one or more host jurisdictions. To ensure that these tax consequences do not adversely affect you, the Company will provide tax equalization in accordance with the terms of this letter, as may be amended from time to time.

Tax Equalization

…

EX-10.10·10-Q·CIK 1487712·ACC 0001628280-26-055220·Filed Aug 10, 2026, 16:08 ET